Developed & Manufactured by Biomedica

High quality ELISAs
Developed and manufactured by Biomedica

Featured Products & Promotions

Latest News
  • Biomarkers of Oxidative Stress in Cardiovascular Diseases
    Biomarkers of Oxidative Stress in Cardiovascular Diseases
    24 February, 2026
    Worldwide, cardiovascular diseases (CVDs) are the primary cause of mortality (1). They involve a variety of underlying mechanisms, with increased oxidative stress being one of the key contributing factors. Behavioral risk factors like poor diet, lack of physical activity, and tobacco use are connected to CVDs. Conditions that heighten the risk include obesity, high blood [...]
  • NT-proBNP at Dialysis Initiation-Predictor of Heart Disease Hospitalization
    NT-proBNP at Dialysis Initiation-Predictor of Heart Disease Hospitalization
    16 February, 2026
    NT-proBNP at Dialysis Initiation-Predictor of Heart Disease Hospitalization: Patients with end-stage kidney disease (ESKD) face a cardiovascular (CV) death risk approximately 10 to 20 times higher than that of the general population. Cardiac biomarkers serve as a valuable tool to predict CV morbidity and mortality in asymptomatic individuals. About NT-proBNP N-terminal pro-BNP (NT-proBNP) is a [...]
  • Prognostic value of Big Endothelin-1 in heart failure
    Prognostic value of Big Endothelin-1 in heart failure
    10 February, 2026
    Big Endothelin-1 (Big ET-1) is the precursor to the most potent vasoconstrictor peptide Endothelin-1 (ET-1), which is mainly produced by endothelial cells (1). Interestingly, there is evidence of stimulated ET-1 release from various immune cells, including macrophages and dendritic cells, indicating that these cells can also synthesize ET-1 (2). While ET-1 is essential in regulating [...]
More News
Events
  • Biomedica at Osteologie in Salzburg
    19 June, 2023
    Biomedica features FGF23 ELISA - intact and C-terminal - assays Meet us at the OSTEOLOGIE Conference taking place from 22-24 June 2023 in Salzburg, Austria! We will exhibit at booth # 36 introducing our novel biomarker ELISA assays to investigate bone and cancer induced bone diseases (e.g. Periostin, Semaphorin 4D, LRG, and others). Our focus [...]
  • Biomedica @ Osteologie 2020 in Salzburg
    17 February, 2020
    Meet us at the Osteologie 2020, hosted by the Deutsche Gesellschaft für Endokrinologie and the Österreichische Gesellschaft für Knochen- und Mineralstoffwechsel, taking place from 12-14 March 2020 in Salzburg, Austria! We will exhibit together with our partners Fianostics & TAmiRNA at booth #1. Moreover,  we will present out new VEGF-A ELISA at our poster "Novel VEGF-A ELISA [...]
  • Meet Biomedica at ASN Kidney Week
    7 November, 2019
    Meet us during ASN Kidney Week taking place from November 5-10 2019 in Washington, DC at booth no. 2005 Hosted by the American Society of Nephrology it’s the world’s premier nephrology meeting with more than 13,000 kidney specialists from across the globe. It provides participants with exciting and challenging opportunities to exchange knowledge, learn about [...]
More Events